Advertisement

Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles

  • K. Iqbal
  • A. del C. Alonso
  • C.-X. Gong
  • S. Khatoon
  • J.-J. Pei
  • J. Z. Wang
  • I. Grundke-Iqbal
Part of the Journal of Neural Transmission. Supplementa book series (NEURAL SUPPL, volume 53)

Summary

Alzheimer disease (AD) has polyetiology. Independent of the etiology the disease is characterized histopathologically by the intraneuronal accumulation of paired helical filaments (PHF), forming neurofibrillary tangles, neuropil threads and dystrophic neurites surrounding the extracellular deposits of β-amyloid in plaques, the second major lesion. The clinical expression of AD correlates with the presence of neurofibrillary degeneration; β-amyloid alone does not produce the disease clinically. Thus arresting neurofibrillary degeneration offers a promising key target for therapeutic intervention of AD. The major protein subunit of PHF is the microtubule-associated protein tau. Tau in AD brain, especially PHF, is abnormally hyperphosphorylated and glycosylated. With maturation, the tangles are increasingly ubiquitinated. Levels of tau and conjugated ubiquitin are elevated both in AD brain and CSF. The AD abnormally phosphorylated tau (AD P-tau) does not promote microtubule assembly, but on dephosphorylation its microtubule promoting activity is restored to approximately that of the normal tau. The AD P-tau competes with tubulin in binding to normal tau, MAPI and MAP2 and inhibits their microtubule assembly promoting activities. Furthermore, the AD P-tau sequesters normal MAPs from microtubules. The association of AD P-tau with normal tau but not with MAPI or MAP2 results in the formation of tangles of 3.3 ± 0.5 mm filaments. Deglycosylation of Alzheimer neurofibrillary tangles with endoglycosidase F/N-glycosidase F untwists the PHF resulting in tangles of thin filaments similar to those formed by association between the AD P-tau and normal tau. Dephosphorylation or deglycosylation plus dephosphorylation but not deglycosylation alone restores the microtubule assembly promoting activity of tau. In vitro AD P-tau can be dephosphorylated by protein phosphatases PP-2B, PP-2A and PP-1 but not PP-2C and all the three tau phosphatases are present in brain neurons. Tau phosphatase activity is decreased by ∼30% in AD brain. Inhibition of PP-2A and PP-1 activities in SY5Y neuroblastoma by 10nM okadaic acid causes breakdown of microtubules and the degeneration of these cells. It is suggested (I) that a defect(s) in the protein phosphorylation/dephosphorylation system(s) leads to a hyperphosphorylation of tau, (ii) that this altered tau causes disassembly of microtubules and consequently a retrograde neuronal degeneration; (iii) a pharmacological approach to AD is to enhance the tau phosphatase activity; and (iv) that CSF tau and conjugated ubiquitin levels are promising markers of AD brain pathology.

Keywords

Neurofibrillary Tangle Microtubule Assembly Paired Helical Filament Neurofibrillary Degeneration Paired Helical Filament 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alafuzoff I, Iqbal K, Friden H, Adolfsson R, Winblad B (1987) Histopathological criteria for progressive dementia disorders: clinical-pathological correlation and classification by multivariate data analysis. Acta Neuropathol 74: 209–225PubMedCrossRefGoogle Scholar
  2. Alonso A del C, Zaidi T, Grundke-Iqbal I, Iqbal K (1994) Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease. Proc Natl Acad Sci USA 91: 5562–5566PubMedCrossRefGoogle Scholar
  3. Alonso A del C, Grundke-Iqbal I, Iqbal K (1996) Alzheimer’s disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nature Med 2: 783–787PubMedCrossRefGoogle Scholar
  4. Alonso A del C, Grundke-Iqbal I, Barra HS, Iqbal K (1997) Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of MAPI and MAP2 and the disassembly of microtubules by the abnormal tau. Proc Natl Acad Sci USA 94: 298–303PubMedCrossRefGoogle Scholar
  5. Arigada PA, Growdon JH, Hedley-White ET, Hyman BT (1992) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer’s disease. Neurology 42: 631–639CrossRefGoogle Scholar
  6. Bancher C, Brunner C, Lassmann H, Budka H, Jellinger K, Wiche G, Seitelberger F, Grundke-Iqbal I, Iqbal K, Wisniewski HM (1989) Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer’s disease. Brain Res 477: 90–99PubMedCrossRefGoogle Scholar
  7. Bancher C, Grundke-Iqbal I, Iqbal K, Fried VA, Smith HT, Wisniewski HM (1991) Abnormal phosphorylation of tau precedes ubiquitination in neurofibrillary pathology of Alzheimer disease. Brain Res 539: 11–18PubMedCrossRefGoogle Scholar
  8. Barcikowska M, Wisniewski HM, Bancher C, Grundke-Iqbal I (1989) About the presence of paired helical filaments in dystrophic neurites participating in the plaque formation. Acta Neuropathol 78: 225–231PubMedCrossRefGoogle Scholar
  9. Baudier J, Cole D (1987) Phosphorylation of tau proteins to a state like that in Alzheimer’s brain is catalyzed by a calcium/calmodulin-dependent kinase and modulated by phospholipds. J Biol Chem 262: 17577–17583PubMedGoogle Scholar
  10. Braak H, Braak E, Grundke-Iqbal I, Iqbal K (1986) Occurrence of neuropil threads in the senile human brain and in Alzheimer’s disease: a third location of paired helical filaments outside of neurofibrillary tangles and neuritic plaques. Neurosci Lett 65: 351–355PubMedCrossRefGoogle Scholar
  11. Cohen P (1989) The structure and regulation of protein phosphatases. Annu Rev Biochem 58: 453–508PubMedCrossRefGoogle Scholar
  12. Dickson DW, Crystal HA, Mattiace LA, Masur DM, Blau AD, Davies P, Yen S-H, Aronson M (1991) Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging 13: 179–189CrossRefGoogle Scholar
  13. Drewes G, Lichtenberg-Kraag B, Döring F, Mandelkow E-M, Biernat J, Goris J, Doree M, Mandelkow E (1992) Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer-like state. EMBO J 11: 2131–2138PubMedGoogle Scholar
  14. Finch C, Tanzi RE (1997) Genetics of aging. Science 278: 407–411PubMedCrossRefGoogle Scholar
  15. Glenner GG, Wong CW (1984) Alzheimer’s disease and Down’s syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun 122: 1131–1135PubMedCrossRefGoogle Scholar
  16. Goedert M, Cohen ES, Jakes R, Cohen P (1992) P42 map kinase phosphorylation sites in microtubule-associated protein tau are dephosphorylated by protein phosphatase 2Ap implications for Alzheimer’s disease. FEBS Lett 312: 95–99PubMedCrossRefGoogle Scholar
  17. Gong C-X, Singh TJ, Grundke-Iqbal I, Iqbal K (1993) Phosphoprotein phosphatase activities in Alzheimer disease. J Neurochem 61: 921–927PubMedCrossRefGoogle Scholar
  18. Gong C-X, Singh TJ, Grundke-Iqbal I, Iqbal K (1994a) Alzheimer disease abnormally phosphorylated tau is dephosphorylated by protein phosphatase 2B (calcineurin). J Neurochem 62: 803–806PubMedCrossRefGoogle Scholar
  19. Gong C-X, Grundke-Iqbal I, Iqbal K (1994b) Dephosphorylation of Alzheimer disease abnormally phosphorylated tau by protein phosphatase-2A. Neuroscience 61: 765–772PubMedCrossRefGoogle Scholar
  20. Gong C-X, Grundke-Iqbal I, Damuni Z, Iqbal K (1994c) Dephosphorylation of microtubule-associated protein tau by protein phosphatase-1 and-2C and its implication in Alzheimer disease. FEBS Lett 341: 94–98PubMedCrossRefGoogle Scholar
  21. Gong C-X, Shaikh S, Wang J-Z, Zaidi T, Grundke-Iqbal I, Iqbal K (1995) Phosphatase activity toward abnormally phosphorylated τ: decrease in Alzheimer disease brain. J Neurochem 65: 732–738PubMedCrossRefGoogle Scholar
  22. Grundke-Iqbal I, Iqbal K, Quinlan M, Tung Y-C, Zaidi MS, Wisniewski HM (1986a) Microtubule-associated protein tau: a component of Alzheimer paired helical filaments. J Biol Chem 261: 6084–6089PubMedGoogle Scholar
  23. Grundke-Iqbal I, Iqbal K, Tung Y-C, Quinlan M, Wisniewski HM, Binder LI (1986b) Abnormal phosphorylation of the microtubule associated protein τ(tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 83: 4913–4917PubMedCrossRefGoogle Scholar
  24. Grundke-Iqbal I, Vorbrodt AW, Iqbal K, Tung YC, Wang GP, Wisniewski HM (1988) Microtubule-associated polypeptides tau are altered in Alzheimer paired helical filaments. Mol Brain Res 4: 43–52CrossRefGoogle Scholar
  25. Ingebritsen TS, Cohen P (1983) The protein phosphatases involved in cellular regulation. Classification and substrate specificities. Eur J Biochem 132: 255–261CrossRefGoogle Scholar
  26. Iqbal K, Grundke-Iqbal I (1995) Alzheimer abnormally phosphorylated tau is more hyperphosphorylated than the fetal tau and causes the disruption of microtubules. Neurobiol Aging 16: 375–379CrossRefGoogle Scholar
  27. Iqbal K, Grundke-Iqbal I, Zaidi T, Merz PA, Wen GY, Shaika SS, Wisniewski HM, Alafuzoff I, Winblad B (1986) Defective brain microtubule assembly in Alzheimer’s disease. Lancet ii: 421–426CrossRefGoogle Scholar
  28. Iqbal K, Grundke-Iqbal I, Smith AJ, George L, Tung Y-C, Zaidi T (1989) Identification and localization of a tau peptide to paired helical filaments of Alzheimer disease. Proc Natl Acad Sci USA 86: 5646–5650PubMedCrossRefGoogle Scholar
  29. Iqbal K, Zaidi T, Bancher C, Grundke-Iqbal I (1994) Alzheimer paired helical filaments: Restoration of the biological activity by dephosphorylation. FEBS Lett 349: 104–108PubMedCrossRefGoogle Scholar
  30. Ishiguro K, Takamatsu M, Tomizawa K, Omori A, Takahashi M, Arioka M, Uchida T, Imahori K (1992) Tau protein kinase I converts normal tau protein into A68-like component of paired helical filaments. J Biol Chem 267: 10897–10901PubMedGoogle Scholar
  31. Khatoon S, Grundke-Iqbal I, Iqbal K (1992) Brain levels of microtubule-associated protein tau are elevated in Alzheimer’s disease: a radioimmuno-slot-blot assay for nanograms of the protein. J Neurochem 59: 750–753PubMedCrossRefGoogle Scholar
  32. Khatoon S, Grundke-Iqbal I, Iqbal K (1994) Levels of normal and abnormally phosphorylated tau in different cellular and regional compartments of Alzheimer disease and control brains. FEBS Lett 351: 80–84PubMedCrossRefGoogle Scholar
  33. Khatoon S, Grundke-Iqbal I, Iqbal K (1995) Guanosine triphosphate binding to β-subunit of tubulin in Alzheimer’s disease brain: Role of microtubule-associated protein τ. J Neurochem 64: 777–787PubMedCrossRefGoogle Scholar
  34. Kidd M (1964) Alzheimer’s disease: an electron microscopical study. Brain 87: 307–320PubMedCrossRefGoogle Scholar
  35. Köpke E, Tung Y-C, Shaika S, Alonso A del C, Iqbal K, Grundke-Iqbal I (1993) Microtubule associated protein tau: abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease. J Biol Chem 268: 24374–24383PubMedGoogle Scholar
  36. Kudo T, Iqbal K, Ravid R, Swaab DF, Grundke-Iqbal I (1994) Alzheimer disease: correlation of cerebrospinal fluid and brain ubiquitin levels. Brain Res 639: 1–7PubMedCrossRefGoogle Scholar
  37. Ledesma MD, Correas I, Avila J, Diaz-Nido J (1992) Implication of brain cdc2 and MAP2 kinases in the phosphorylation of tau protein in Alzheimer’s disease. FEBS Lett 308: 218–224PubMedCrossRefGoogle Scholar
  38. Lindwall G, Cole RD (1984) Phosphorylation affects the ability of tau protein to promote microtubule assembly. J Biol Chem 259: 5301–5305PubMedGoogle Scholar
  39. Litersky JM, Johnson GVW (1992) Phosphorylation by cAMP-dependent protein kinase inhibits the degradation of tau by calpain. J Biol Chem 267: 1563–1568PubMedGoogle Scholar
  40. Morishima-Kawashima M, Hasegawa M, Takio K, Suzuki M, Yoshida H, Watanabe A, Titani K, Ihara Y (1995) Hyperphosphorylation of tau in PHF. Neurobiol Aging 16: 365–380PubMedCrossRefGoogle Scholar
  41. Motter R, Vigo-Pelfrey C, Kholodenko D, Barbour R, Johnson-Wood K, Galasko D, Chang L, Miller B, Clark C, Green R, Olson D, Southwick P, Wolfert R, Munroe B, Lieberburg I, Seubert P, Schenk D (1995) Reduction of β-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer’s disease. Ann Neurol 38: 643–648PubMedCrossRefGoogle Scholar
  42. Pei J-J, Sersen E, Iqbal K, Grundke-Iqbal I (1994) Expression of protein phosphatases PP-1, PP-2A, PP-2B and PTP-1B and protein kinases MAP kinase and P34cdc2 in the hippocampus of patients with Alzheimer disease and normal aged individuals. Brain Res 655: 70–76PubMedCrossRefGoogle Scholar
  43. Roder HM, Ingram VM (1991) Two novel kinases phosphorylate tau and KSP site of heavy neurofilament subunits in high stoichiometric ratios. J Neurosci 11: 3325–3343PubMedGoogle Scholar
  44. Singh TJ, Grundke-Iqbal I, McDonald B, Iqbal K (1994) Comparison of the phosphorylation of microtubule associated protein tau by non-proline dependent protein kinases. Mol Cell Biochem 131: 181–189PubMedCrossRefGoogle Scholar
  45. Terry RD, Gonatas NK, Weiss M (1964) Ultrastructural studies in Alzheimer’s presenile dementia. Am J Pathol 44: 269–297PubMedGoogle Scholar
  46. Terry RDD, Wisniewski HM (1972) Ultrastructure of senile dementia and of experimental analogs. In: Aging and the brain: advances in behavioral biology, vol 3. Plenum Press, New York, p 231Google Scholar
  47. Tomlinson BE, Blessed G, Roth M (1970) Observations on the brains of demented old people. J Neurol Sci 11: 205–242PubMedCrossRefGoogle Scholar
  48. Vandermeeren M, Lubke U, Six J, Cras P (1993) The phosphatase inhibitor okadaic acid induces a phosphorylated paired helical filament tau epitope in human L-A-N-5 neuroblastoma cells. Neurosci Lett 153: 57–60PubMedCrossRefGoogle Scholar
  49. Vigo-Pelfrey C, Seubert P, Barbour R, Blomquist C, Lee M, Lee D, Coria F, Chang L, Miller B, Lieberburg I, Schenk D (1995) Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer’s disease. Neurology 45: 788–793PubMedCrossRefGoogle Scholar
  50. Wang GP, Grundke-Iqbal I, Kascsak RJ, Iqbal K, Wisniewski HM (1984) Alzheimer neurofibrillary tangles: monoclonal antibodies to inherent antigen/s. Acta Neuropathol 62: 268–275PubMedCrossRefGoogle Scholar
  51. Wang GP, Iqbal K, Bucht G, Winblad B, Wisniewski HM, Grundke-Iqbal I (1991a) Alzheimer’s disease: paired helical filament immunoreactivity in cerebrospinal fluid. Acta Neuropathol 82: 6–12PubMedCrossRefGoogle Scholar
  52. Wang GP, Khatoon S, Iqbal I, Grundke-Iqbal I (1991b) Brain ubiquitin is markedly elevated in Alzheimer disease. Brain Res 566: 146–151PubMedCrossRefGoogle Scholar
  53. Wang J-Z, Gong C-X, Zaidi T, Grundke-Iqbal I, Iqbal K (1995) Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and-2B. J Biol Chem 270: 4854–4860PubMedCrossRefGoogle Scholar
  54. Wang J-Z, Grundke-Iqbal I, Iqbal K (1996) Restoration of biological activity of Alzheimer abnormally phosphorylated τ by dephosphorylation with protein phosphatase-2A,-2B and 1. Mol Brain Res 38: 200–208PubMedCrossRefGoogle Scholar
  55. Wang J-Z, Grundke-Iqbal I, Iqbal K (1996) Glycosylation of microtubule-associated protein tau: An abnormal post-translation modification in Alzheimer’s disease. Nature Med 2: 871–875PubMedCrossRefGoogle Scholar
  56. Weingarten MD, Lockwood AH, Hwo S-Y, Kirschner MW (1975) A protein of mammalian brain and its relation to microtubule assembly. Proc Natl Acad Sci USA 72: 1858–1862PubMedCrossRefGoogle Scholar
  57. Weisenberg RC, Borisy GC, Taylor EW (1968) The colchicine binding protein of mammalian brain and its relation to microtubules. Biochemistry 7: 4466–4477PubMedCrossRefGoogle Scholar
  58. Weisenberg RC, Denny WJ, Dickinson PJ (1976) Tubulin-nucleotide interactions during the polymerization and depolymerization of microtubules. Biochemistry 15: 4248–4254PubMedCrossRefGoogle Scholar
  59. Wisniewski HM, Terry RD (1973) Morphology of the aging brain, human and animal. Prog Brain Res 40: 184–186Google Scholar

Copyright information

© Springer-Verlag Wien 1998

Authors and Affiliations

  • K. Iqbal
    • 1
    • 2
  • A. del C. Alonso
    • 1
  • C.-X. Gong
    • 1
  • S. Khatoon
    • 1
  • J.-J. Pei
    • 1
  • J. Z. Wang
    • 1
  • I. Grundke-Iqbal
    • 1
  1. 1.New York State Institute for Basic Research in Development DisabilitiesStaten IslandUSA
  2. 2.NYS Institute for Basic Research in Developmental DisabilitiesStaten IslandUSA

Personalised recommendations